Report Detail
Global Amiodarone Market Professional Survey Report 2019
- RnM3801072 |
- 03 October, 2019 |
- Global |
- 103 Pages |
- QYResearch |
- Pharma & Healthcare
Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.
The global Amiodarone market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Amiodarone volume and value at global level, regional level and company level. From a global perspective, this report represents overall Amiodarone market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Amiodarone in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Amiodarone manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi
Sawai Pharmaceutical
Wyeth Pharmaceuticals (Pfizer)
Mylan Pharmaceuticals
Arrow Pharma Pty Ltd
Roemmers
Cipla Pharmaceutical
Shanghai Pharmaceuticals
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Tablet
Capsule
Injection
Segment by Application
Cardiac Arrest
Ventricular Tachycardia
Atrial Fibrillation
Others
Table of Contents
Executive Summary
1 Industry Overview of Amiodarone
- 1.1 Definition of Amiodarone
- 1.2 Amiodarone Segment by Type
- 1.2.1 Global Amiodarone Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Tablet
- 1.2.3 Capsule
- 1.2.4 Injection
- 1.3 Amiodarone Segment by Applications
- 1.3.1 Global Amiodarone Consumption Comparison by Applications (2014-2025)
- 1.3.2 Cardiac Arrest
- 1.3.3 Ventricular Tachycardia
- 1.3.4 Atrial Fibrillation
- 1.3.5 Others
- 1.4 Global Amiodarone Overall Market
- 1.4.1 Global Amiodarone Revenue (2014-2025)
- 1.4.2 Global Amiodarone Production (2014-2025)
- 1.4.3 North America Amiodarone Status and Prospect (2014-2025)
- 1.4.4 Europe Amiodarone Status and Prospect (2014-2025)
- 1.4.5 China Amiodarone Status and Prospect (2014-2025)
- 1.4.6 Japan Amiodarone Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Amiodarone Status and Prospect (2014-2025)
- 1.4.8 India Amiodarone Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Amiodarone
- 2.3 Manufacturing Process Analysis of Amiodarone
- 2.4 Industry Chain Structure of Amiodarone
3 Development and Manufacturing Plants Analysis of Amiodarone
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Amiodarone Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Amiodarone
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Amiodarone Production and Capacity Analysis
- 4.2 Amiodarone Revenue Analysis
- 4.3 Amiodarone Price Analysis
- 4.4 Market Concentration Degree
5 Amiodarone Regional Market Analysis
- 5.1 Amiodarone Production by Regions
- 5.1.1 Global Amiodarone Production by Regions
- 5.1.2 Global Amiodarone Revenue by Regions
- 5.2 Amiodarone Consumption by Regions
- 5.3 North America Amiodarone Market Analysis
- 5.3.1 North America Amiodarone Production
- 5.3.2 North America Amiodarone Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Amiodarone Import and Export
- 5.4 Europe Amiodarone Market Analysis
- 5.4.1 Europe Amiodarone Production
- 5.4.2 Europe Amiodarone Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Amiodarone Import and Export
- 5.5 China Amiodarone Market Analysis
- 5.5.1 China Amiodarone Production
- 5.5.2 China Amiodarone Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Amiodarone Import and Export
- 5.6 Japan Amiodarone Market Analysis
- 5.6.1 Japan Amiodarone Production
- 5.6.2 Japan Amiodarone Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Amiodarone Import and Export
- 5.7 Southeast Asia Amiodarone Market Analysis
- 5.7.1 Southeast Asia Amiodarone Production
- 5.7.2 Southeast Asia Amiodarone Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Amiodarone Import and Export
- 5.8 India Amiodarone Market Analysis
- 5.8.1 India Amiodarone Production
- 5.8.2 India Amiodarone Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Amiodarone Import and Export
6 Amiodarone Segment Market Analysis (by Type)
- 6.1 Global Amiodarone Production by Type
- 6.2 Global Amiodarone Revenue by Type
- 6.3 Amiodarone Price by Type
7 Amiodarone Segment Market Analysis (by Application)
- 7.1 Global Amiodarone Consumption by Application
- 7.2 Global Amiodarone Consumption Market Share by Application (2014-2019)
8 Amiodarone Major Manufacturers Analysis
- 8.1 Sanofi
- 8.1.1 Sanofi Amiodarone Production Sites and Area Served
- 8.1.2 Sanofi Product Introduction, Application and Specification
- 8.1.3 Sanofi Amiodarone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Sawai Pharmaceutical
- 8.2.1 Sawai Pharmaceutical Amiodarone Production Sites and Area Served
- 8.2.2 Sawai Pharmaceutical Product Introduction, Application and Specification
- 8.2.3 Sawai Pharmaceutical Amiodarone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Wyeth Pharmaceuticals (Pfizer)
- 8.3.1 Wyeth Pharmaceuticals (Pfizer) Amiodarone Production Sites and Area Served
- 8.3.2 Wyeth Pharmaceuticals (Pfizer) Product Introduction, Application and Specification
- 8.3.3 Wyeth Pharmaceuticals (Pfizer) Amiodarone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Mylan Pharmaceuticals
- 8.4.1 Mylan Pharmaceuticals Amiodarone Production Sites and Area Served
- 8.4.2 Mylan Pharmaceuticals Product Introduction, Application and Specification
- 8.4.3 Mylan Pharmaceuticals Amiodarone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Arrow Pharma Pty Ltd
- 8.5.1 Arrow Pharma Pty Ltd Amiodarone Production Sites and Area Served
- 8.5.2 Arrow Pharma Pty Ltd Product Introduction, Application and Specification
- 8.5.3 Arrow Pharma Pty Ltd Amiodarone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Roemmers
- 8.6.1 Roemmers Amiodarone Production Sites and Area Served
- 8.6.2 Roemmers Product Introduction, Application and Specification
- 8.6.3 Roemmers Amiodarone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Cipla Pharmaceutical
- 8.7.1 Cipla Pharmaceutical Amiodarone Production Sites and Area Served
- 8.7.2 Cipla Pharmaceutical Product Introduction, Application and Specification
- 8.7.3 Cipla Pharmaceutical Amiodarone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Shanghai Pharmaceuticals
- 8.8.1 Shanghai Pharmaceuticals Amiodarone Production Sites and Area Served
- 8.8.2 Shanghai Pharmaceuticals Product Introduction, Application and Specification
- 8.8.3 Shanghai Pharmaceuticals Amiodarone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 North China Pharmaceutical Company
- 8.9.1 North China Pharmaceutical Company Amiodarone Production Sites and Area Served
- 8.9.2 North China Pharmaceutical Company Product Introduction, Application and Specification
- 8.9.3 North China Pharmaceutical Company Amiodarone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Harbin Pharmaceutical Group
- 8.10.1 Harbin Pharmaceutical Group Amiodarone Production Sites and Area Served
- 8.10.2 Harbin Pharmaceutical Group Product Introduction, Application and Specification
- 8.10.3 Harbin Pharmaceutical Group Amiodarone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Amiodarone Market
- 9.1 Global Amiodarone Market Trend Analysis
- 9.1.1 Global Amiodarone Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Amiodarone Regional Market Trend
- 9.2.1 North America Amiodarone Forecast 2019-2025
- 9.2.2 Europe Amiodarone Forecast 2019-2025
- 9.2.3 China Amiodarone Forecast 2019-2025
- 9.2.4 Japan Amiodarone Forecast 2019-2025
- 9.2.5 Southeast Asia Amiodarone Forecast 2019-2025
- 9.2.6 India Amiodarone Forecast 2019-2025
- 9.3 Amiodarone Market Trend (Product Type)
- 9.4 Amiodarone Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Amiodarone Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Amiodarone. Industry analysis & Market Report on Amiodarone is a syndicated market report, published as Global Amiodarone Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Amiodarone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
